Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory
- PMID: 20690131
- DOI: 10.1002/gps.2499
Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory
Abstract
Objective: The aim of the study was to estimate inter-observer and test-retest reliability of the Neuropsychiatric Inventory Nursing Home version (NPI-NH) and the Cohen-Mansfield Agitation Inventory (CMAI), and to establish their Reliable Change Index (RCI). Reliable Change methodology is a practical method for estimating the least change acquired in outcome measures.
Methods: Nursing home physicians and certified nurses assessed 105 patients with dementia (in five nursing homes) at baseline and after 2 weeks. Spearman rank correlations were calculated and Reliable Change Difference Scores (S(diff) (80)).
Results: NPI-NH inter-observer correlations ranged 0.14-0.70. NPI-NH test-retest correlations ranged 0.23-0.80. CMAI inter-observer correlations ranged -0.10 to 0.72. CMAI test-retest correlations ranged 0.32-1.00 (CMAI total score, ρ=0.89). S(diff) (80) for NPI-NH items ranged 1.7-5.0. A change of 11 points on the NPI-NH total score can be considered a true behavioral change. S(diff) (80) for CMAI total score was 8 and factor analysis based sub-scale scores physically aggressive behavior, physically non-aggressive behavior, and verbally agitated behavior were 3, 6, and 4, respectively.
Conclusion: Reliability estimates and RCI for the NPI-NH were modest, seriously challenging its reliability and sensitivity to change over time. NPI-NH may only be useful for monitoring behavioral changes in individual patients with dementia, when symptoms are moderate to severe, or when effect sizes are large. Reliability of the CMAI was good, supporting its usefulness in clinical practice. Poor inter-observer agreement on behavioral observations poses a real challenge in nursing homes. Reliable scales are needed that include unambiguously formulated items.
Copyright © 2010 John Wiley & Sons, Ltd.
Similar articles
-
[Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)].Brain Nerve. 2008 Dec;60(12):1463-9. Brain Nerve. 2008. PMID: 19110758 Japanese.
-
Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia.Int J Geriatr Psychiatry. 2007 Jul;22(7):632-8. doi: 10.1002/gps.1722. Int J Geriatr Psychiatry. 2007. PMID: 17136713
-
[Reliability of The Cohen-Mansfield Agitation Inventory Polish version among demented and non-demented nursing home residents].Psychiatr Pol. 2007 Nov-Dec;41(6):789-97. Psychiatr Pol. 2007. PMID: 18540422 Polish.
-
Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.J Clin Psychiatry. 2001;62 Suppl 21:19-22. J Clin Psychiatry. 2001. PMID: 11584983 Review.
-
Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument.Int Psychogeriatr. 1996;8 Suppl 3:309-15; discussion 351-4. doi: 10.1017/s1041610297003530. Int Psychogeriatr. 1996. PMID: 9154580 Review. No abstract available.
Cited by
-
Carer coping and resident agitation as predictors of quality of life in care home residents living with dementia: Managing Agitation and Raising Quality of Life (MARQUE) English national care home prospective cohort study.Int J Geriatr Psychiatry. 2019 Jan;34(1):106-113. doi: 10.1002/gps.4994. Epub 2018 Oct 1. Int J Geriatr Psychiatry. 2019. PMID: 30276865 Free PMC article.
-
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456. doi: 10.1111/bcp.13604. Epub 2018 May 14. Br J Clin Pharmacol. 2018. PMID: 29637593 Free PMC article.
-
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2. PLoS One. 2012. PMID: 22567095 Free PMC article. Clinical Trial.
-
Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia.Front Pharmacol. 2020 Feb 21;10:1701. doi: 10.3389/fphar.2019.01701. eCollection 2019. Front Pharmacol. 2020. PMID: 32153391 Free PMC article.
-
Non-pharmacological, psychosocial MAKS-s intervention for people with severe dementia in nursing homes: results of a cluster-randomised trial.BMC Geriatr. 2022 Dec 28;22(1):1001. doi: 10.1186/s12877-022-03695-z. BMC Geriatr. 2022. PMID: 36577973 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical